1. Adrian RW, Ismail S, Jahn U (1983) Pharmacological studies with beclobrate, a new hypolipidemic agent. Arzneimittelforschung 33: 1464–1468
2. Anwer K, Gabis J, Romstedt K, Gojer C, Akbar H (1985) Beclobrinic acid — a new hypolipidemic agent — inhibits in vitro human platelet activation by blocking prostaglandin synthesis. Life Sci 37: 63–70
3. Avogaro P, Bittolo Bon G, Gazzolato G, Soldan S (1990) Beclobrate vs bezafibrate in the treatment of type IIB hyperlipoproteinemia. In: Kostner GM, Sirtori CR (eds) Beclobrate, a new lipoprotein regulator. Hogrefe & Huber, Toronto Stuttgart, pp 39–44
4. Baitsch G, Walter N (1990) Comparative hypolipidemic potency and safety of beclobrate, gemfibrozil, and various forms of diet. In: Kostner GM, Sirtori CR (eds) Beclobrate, a new lipoprotein regulator. Hogrefe & Huber, Toronto Stuttgart, pp 50–56
5. Desager JP, Hauglustaine D, Harvengt C (1990) Hemodialysis and the plasma kinetics of beclobrate. In: Kostner GM, Sirtori CR (eds) Beclobrate, a new lipoprotein regulator. Hogrefe & Huber, Toronto Stuttgart, pp 83–87